FormDSignal

Entera Bio Ltd. (ENTX)

1 Item 5.02 filing since 2026-10-27 · 1 with an open seat · roles: Director. Nasdaq. Biological Products, (No Diagnostic Substances).

ScoreFiledEventRolePersonSeatSummary
302026-10-27DepartureDirectorsubscribersOpenEntera Bio Ltd. (ENTX): director Haya Taitel resigned

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works